✦ LIBER ✦

ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non–small cell lung cancer

✍ Scribed by David Raben; Barbara A. Helfrich; Dan Chan; Gary Johnson; Paul A. Bunn Jr

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erlotinib (OSI-774, Tarceva™), a Selecti

✍ Mary Hightower; Chandra P. Belani; Vinay K. Jain 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 78 KB

Epidermal growth factor receptor tyrosin

✍ Carrera, S.; Buque, A.; Azkona, E.; Aresti, U.; Calvo, B.; Sancho, A.; Arruti, M 📂 Article 📅 2013 🏛 Springer Milan 🌐 Spanish ⚖ 645 KB

Antitumor activity of the epidermal grow

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Objective regressions in non-small cell

✍ Kris, M.G; Herbst, R; Rischin, D; LoRusso, P; Baselga, J; Hammond, L; Feyereislo 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

ZD1839, a novel, oral epidermal growth f

✍ Pallis, A.G.; Mavroudis, D.; Androulakis, N.; Souglakos, J.; Kouroussis, C.; Boz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Pilot trial of ZD1839 (IressaTM), an ora

✍ Laurie, S.A; Miller, V.A; Johnson, D; Ng, K.K; Heelan, R.T; Pizzo, B.A; Perez, W 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB